Emma Tham Selected Research

Emma Tham Research Topics

Disease

14	Neoplasms (Cancer) 02/2024 - 05/2005
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2024 - 10/2022
3	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 10/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2019
2	Microsatellite Instability 04/2020 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2005
1	Brain Stem Neoplasms (Brain Stem Tumor) 02/2024
1	Hydrocephalus (Hydrocephaly) 02/2024
1	Astrocytoma (Pilocytic Astrocytoma) 01/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023
1	Medulloblastoma 03/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Malformations of Cortical Development 12/2021
1	congenital fibrosis of the extraocular muscles 12/2021
1	Obesity 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Follicular Adenocarcinoma 01/2020
1	Cone-Rod Dystrophies 01/2020
1	Lymphatic Metastasis 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Anaplastic Thyroid Carcinoma 01/2020
1	Intellectual Disability (Idiocy) 11/2019
1	Circulating Neoplastic Cells 10/2019
1	Primary Hyperparathyroidism 01/2019
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2019
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 02/2016
1	Uterine Neoplasms (Uterine Cancer) 04/2015
1	Multiple Hamartoma Syndrome (Cowden's Disease) 04/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011
1	Chronic Progressive Multiple Sclerosis 05/2011
1	Dermatomyositis (Dermatopolymyositis) 10/2008
1	Polymyositis 10/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2002
1	Hypoxia (Hypoxemia) 07/2002

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2016
6	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2021
5	Circulating Tumor DNAIBA 01/2024 - 10/2019
4	NucleotidesIBA 03/2023 - 11/2019
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011 - 07/2002
2	Cell-Free Nucleic AcidsIBA 03/2023 - 01/2023
1	dabrafenibIBA 02/2024
1	trametinibIBA 02/2024
1	SteroidsIBA 02/2024
1	Chemokine ReceptorsIBA 12/2023
1	ChemokinesIBA 12/2023
1	TubulinIBA 12/2021
1	LDL CholesterolIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	CholesterolIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	LipidsIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	RacivirIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	prolinedithiocarbamate (PDTC)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 10/2019
1	Complement System Proteins (Complement)IBA 10/2019
1	Circulating MicroRNAIBA 10/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2016
1	Transferrin (beta 2 Transferrin)IBA 02/2016
1	Estrogens (Estrogen)FDA Link 10/2015
1	CA-125 Antigen (CA 125 Antigen)IBA 09/2015
1	Tumor Biomarkers (Tumor Markers)IBA 09/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2015
1	TensinsIBA 04/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Hepatocyte Nuclear Factor 1IBA 03/2015
1	Neuroprotective AgentsIBA 05/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2011
1	CathelicidinsIBA 05/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2005
1	Transcription Factors (Transcription Factor)IBA 07/2002
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 07/2002
1	Angiopoietin-1IBA 07/2002

Therapy/Procedure

1	Ventriculoperitoneal Shunt 02/2024
1	Radiotherapy 02/2024
1	Molecular Targeted Therapy 02/2024
1	Neoadjuvant Therapy 12/2023
1	Aftercare (After-Treatment) 10/2022
1	Genomic Medicine 01/2021
1	Therapeutics 10/2019
1	Hysterectomy 09/2015
1	Salpingo-oophorectomy 09/2015